Immune checkpoint inhibitors-related myocarditis in patients with cancer: an analysis of international spontaneous reporting systems
Sign Up to like & getrecommendations! Published in 2021 at "BMC Cancer"
DOI: 10.1186/s12885-020-07741-0
Abstract: Background Immune checkpoint inhibitors-induced myocarditis presents unique clinical challenges. Here, we assessed post-marketing safety of cytotoxic T-lymphocyte-associated protein-4 (CTLA-4), programmed cell death-1 (PD-1), and programmed death-ligand 1 (PD-L1) inhibitors by mining the real-world data reported… read more here.
Keywords: immune checkpoint; related myocarditis; checkpoint inhibitors; cancer ... See more keywords
Immune Checkpoint Inhibitors-Related Myocarditis: A Review of Reported Clinical Cases
Sign Up to like & getrecommendations! Published in 2023 at "Diagnostics"
DOI: 10.3390/diagnostics13071243
Abstract: Myocarditis associated with the use of immune checkpoint inhibitors (ICI) is a rare manifestation of their cardiotoxicity, but is characterized by a high mortality rate. A literature search was conducted using PubMed using keywords, which… read more here.
Keywords: myocarditis; clinical cases; checkpoint inhibitors; immune checkpoint ... See more keywords